Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Join | Sign in

  News Archive

TxCell to Present at Upcoming US and French Investment Conferences
Saturday, March 28, 2015
Conferences include Alliance for Regenerative Medicine's 3rd Annual Regen Med Investor Day, New York, March 25 and the Portzamparc PEA-PME Forum, Paris, April 1.

BioLineRx Reports Successful Top-Line Safety and Efficacy Results
Saturday, March 28, 2015
BL-8040 Phase 1 study met all safety and efficacy endpoints.

apceth Initiates Phase II Clinical Trial for Pioneering Engineered Cell Therapy
Saturday, March 28, 2015
Successfully completed Phase I clinical study and regulatory approval enable world’s first genetically-engineered cell therapy to enter Phase II.

Emergent BioSolutions Receives FDA Approval of Anthrasil
Friday, March 27, 2015
Company’s Anthrax Immune Globulin, for use in the treatment of inhalational anthrax.

Kemwell Announces Successful USFDA Inspection
Friday, March 27, 2015
Company’s oral solids manufacturing facility located in Bangalore, India.

Takeda Licenses Rights to Use ImmunoGen's ADC Technology
Friday, March 27, 2015
To develop and commercialize targeted anticancer therapeutics to up to two undisclosed targets.

BioClinica Opens Research Triangle Park Office
Friday, March 27, 2015
Sponsors and CRO strategic partners drive RTP expansion.

AbbVie and C2N Enter into a Worldwide License Agreement
Friday, March 27, 2015
License agreement to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease.

Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Friday, March 27, 2015
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 3441

SELECTBIO Market Reports
Go to LabTube
Go to eposters